Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 200-206

  Gupta, Nidhi ^a   Xu, Zhihua ^a   El Sehemy, Ahmed ^a   Steed, Helen ^a   Fu, Yangxin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Carboplatin; ERK; Notch3; Ovarian cancer

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBOPLATIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRAL RED; NOTCH3 RECEPTOR; PHOSPHOTRANSFERASE; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MORPHOLOGY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTADIENES; CARBOPLATIN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTORS, NOTCH;

EID: 84879106039     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.019     Document Type: Article

References (49)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. T.A. Yap, C.P. Carden, and S.B. Kaye Beyond chemotherapy: targeted therapies in ovarian cancer Nat Rev Cancer 9 2009 167 181
3. R. Agarwal, and S.B. Kaye Ovarian cancer: strategies for overcoming resistance to chemotherapy Nat Rev Cancer 3 2003 502 516
4. S. Bray, and M. Furriols Notch pathway: making sense of suppressor of hairless Curr Biol 11 2001 R217 R221
5. S. Artavanis-Tsakonas, M.D. Rand, and R.J. Lake Notch signaling: cell fate control and signal integration in development Science 284 1999 770 776
6. T. Iso, Y. Hamamori, and L. Kedes Notch signaling in vascular development Arterioscler Thromb Vasc Biol 23 2003 543 553
7. Y. Nam, P. Sliz, L. Song, J.C. Aster, and S.C. Blacklow Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes Cell 124 2006 973 983
8. L. Wu, T. Sun, K. Kobayashi, P. Gao, and J.D. Griffin Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors Mol Cell Biol 22 2002 7688 7700
9. M. Roy, W.S. Pear, and J.C. Aster The multifaceted role of Notch in cancer Curr Opin Genet Dev 17 2007 52 59
10. K.G. Leong, and A. Karsan Recent insights into the role of Notch signaling in tumorigenesis Blood 107 2006 2223 2233
11. O. Hopfer, D. Zwahlen, M.F. Fey, and S. Aebi The Notch pathway in ovarian carcinomas and adenomas Br J Cancer 93 2005 709 718
12. S.L. Rose Notch signaling pathway in ovarian cancer Int J Gynecol Cancer 19 2009 564 566
13. J.T. Park, M. Li, K. Nakayama, T.L. Mao, B. Davidson, and Z. Zhang Notch3 gene amplification in ovarian cancer Cancer Res 66 2006 6312 6318
14. J.H. Choi, J.T. Park, B. Davidson, P.J. Morin, M. Shih Ie, and T.L. Wang Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion Cancer Res 68 2008 5716 5723
15. S.L. Rose, M. Kunnimalaiyaan, J. Drenzek, and N. Seiler Notch 1 signaling is active in ovarian cancer Gynecol Oncol 117 2010 130 133
16. Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
17. W. Hu, C. Lu, H.H. Dong, J. Huang, D.Y. Shen, and R.L. Stone Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer Cancer Res 71 2011 6030 6039
18. A.D. Steg, A.A. Katre, B. Goodman, H.D. Han, A.M. Nick, and R.L. Stone Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer Clin Cancer Res 17 2011 5674 5685
19. M. Wang, L. Wu, L. Wang, and X. Xin Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780 Biochem Biophys Res Commun 393 2010 144 149
20. J.T. Park, X. Chen, C.G. Trope, B. Davidson, M. Shih Ie, and T.L. Wang Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin Am J Pathol 177 2010 1087 1094
21. S.G. Jung, Y.D. Kwon, J.A. Song, M.J. Back, S.Y. Lee, and C. Lee Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma Cancer Sci 101 2010 1977 1983
22. G. Repetto, A. del Peso, and J.L. Zurita Neutral red uptake assay for the estimation of cell viability/cytotoxicity Nat Protoc 3 2008 1125 1131
23. Y. Fu, H. Sies, and X.G. Lei Opposite roles of selenium-dependent glutathione peroxidase-1 in superoxide generator diquat-and peroxynitrite- induced apoptosis and signaling J Biol Chem 276 2001 43004 43009
24. K.G. Guruharsha, M.W. Kankel, and S. Artavanis-Tsakonas The Notch signalling system: recent insights into the complexity of a conserved pathway Nat Rev Genet 13 2012 654 666
25. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
26. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
27. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
28. A. Voulgari, and A. Pintzas Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic Biochim Biophys Acta 1796 2009 75 90
29. D.J. Stewart Mechanisms of resistance to cisplatin and carboplatin Crit Rev Oncol Hematol 63 2007 12 31
30. L. Galluzzi, L. Senovilla, I. Vitale, J. Michels, I. Martins, and O. Kepp Molecular mechanisms of cisplatin resistance Oncogene 31 2012 1869 1883
31. C. Sheridan, G. Brumatti, M. Elgendy, M. Brunet, and S.J. Martin An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs Oncogene 29 2010 6428 6441
32. L.Y. Chung, S.J. Tang, G.H. Sun, T.Y. Chou, T.S. Yeh, and S.L. Yu Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2 Clin Cancer Res 18 2012 4037 4047
33. J.P. Thiery, and J.P. Sleeman Complex networks orchestrate epithelial-mesenchymal transitions Nat Rev Mol Cell Biol 7 2006 131 142
34. Z. Xu, Y. Jiang, H. Steed, S. Davidge, and Y. Fu TGFbeta and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells Biochem Biophys Res Commun 401 2010 376 381
35. N. Ahmed, E.W. Thompson, and M.A. Quinn Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm J Cell Physiol 213 2007 581 588
36. T.V. Do, L.A. Kubba, H. Du, C.D. Sturgis, and T.K. Woodruff Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition Mol Cancer Res 6 2008 695 705
37. D. Vergara, B. Merlot, J.P. Lucot, P. Collinet, D. Vinatier, and I. Fournier Epithelial-mesenchymal transition in ovarian cancer Cancer Lett 291 2010 59 66
38. B. Davidson, C.G. Trope, and R. Reich Epithelial-mesenchymal transition in ovarian carcinoma Front Oncol 2 2012 33
39. N. Ahmed, K. Abubaker, J. Findlay, and M. Quinn Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer Curr Cancer Drug Targets 10 2010 268 278
40. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, and A. Nawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int J Oncol 31 2007 277 283
41. S. Marchini, R. Fruscio, L. Clivio, L. Beltrame, L. Porcu, and I.F. Nerini Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer Eur J Cancer 49 2013 520 530
42. X. Wang, J.L. Martindale, and N.J. Holbrook Requirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 2000 39435 39443
43. S. Schweyer, A. Soruri, O. Meschter, A. Heintze, F. Zschunke, and N. Miosge Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation Br J Cancer 91 2004 589 598
44. D. Amran, P. Sancho, C. Fernandez, D. Esteban, A.M. Ramos, and E. de Blas Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation Biochim Biophys Acta 1743 2005 269 279
45. M. Nonaka, H. Itamochi, W. Kawaguchi, A. Kudoh, S. Sato, and K. Uegaki Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells Int J Gynecol Cancer 22 2012 922 929
46. J. Hayakawa, M. Ohmichi, H. Kurachi, H. Ikegami, A. Kimura, and T. Matsuoka Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line J Biol Chem 274 1999 31648 31654
47. S. Lee, S. Yoon, and D.H. Kim A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells Gynecol Oncol 104 2007 338 344
48. S.M. McAuliffe, S.L. Morgan, G.A. Wyant, L.T. Tran, K.W. Muto, and Y.S. Chen Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy Proc Natl Acad Sci U S A 109 2012 E2939 E2948
49. M.M. Gounder, and G.K. Schwartz Moving forward one Notch at a time J Clin Oncol 30 2012 2291 2293